Scale and footprint Fareva operates 41 production sites across 13 countries on 3 continents with over 13,000 employees and €2.22 billion in revenue, indicating strong global manufacturing capacity and the potential to offer large-scale contract manufacturing and international supply chain capabilities to prospective clients.

Diverse verticals The company specializes in Pharmaceuticals, Cosmetics, and Industrial & Household products, presenting cross-vertical contract manufacturing opportunities and the ability to tailor solutions for clients seeking multi‑category packaging, formulation, and regulatory support.

Recent expansions New sterile GMP pilot unit in Pau and ongoing site expansions signal capacity growth and capabilities in sterile injectable production, offering opportunities for pharma clients requiring scalable, compliant manufacturing and early-stage development support.

Strategic partnerships Recent collaborations with Albéa and Zhaoke Ophthalmology, as well as longstanding social responsibility initiatives, open doors for co-development, packaging innovation, market entry in China, and enhanced brand value through sustainability and patient-focused programs.

Risk and remediation prompts Regulatory and compliance challenges at a U.S. site and ongoing legal matters with major customers highlight the need for diligence, additional QA/CMC investments, and a sales approach that emphasizes robust quality systems, risk mitigation, and proven performance to restore client confidence.